Athens Medical C.S.A. Capital Reinvestment Ratio

Latest as of June 2023: 1.64x

Athens Medical C.S.A. capital reinvestment ratio. Athens Medical C.S.A. (IATR) has a Capital Reinvestment Ratio of 1.64x as of June 2023, meaning it reinvests 2% of its operating cash flow (€3.17 Million) in capital expenditures (€5.19 Million). See Athens Medical C.S.A. (IATR) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.64x
Capex / Operating Cash Flow

Operating Cash Flow

€3.17 Million
EUR

Capital Expenditures

€5.19 Million
EUR

Data as of

Jun 2023
Most recent filing

Capital Reinvestment Ratio of Athens Medical C.S.A. (2014–2024)

Capital reinvestment ratio of Athens Medical C.S.A. from 2014 to 2024. This chart tracks Athens Medical C.S.A.'s Capital Reinvestment Ratio across 10 annual periods. See Athens Medical C.S.A. (IATR) flexibility index to measure the company's free cash flow as a share of total liabilities.

Athens Medical C.S.A. Capital Reinvestment Ratio by Year (2014–2024)

Athens Medical C.S.A. capital reinvestment ratio by year from 2014 to 2024. For the full cash flow conversion analysis, see IATR cash flow metrics.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2024 0.57x €46.44 Million €26.63 Million ▼ -33.0%
2023 0.86x €26.13 Million €22.35 Million ▼ -99.3%
2022 128.02x €124.00K €15.87 Million ▲ +17767.6%
2021 0.72x €15.75 Million €11.28 Million ▲ +307.0%
2020 0.18x €40.21 Million €7.08 Million ▼ -65.9%
2019 0.52x €31.50 Million €16.27 Million ▲ +29.9%
2018 0.40x €20.02 Million €7.96 Million ▲ +3.1%
2016 0.39x €9.78 Million €3.77 Million ▲ +147.2%
2015 0.16x €12.89 Million €2.01 Million ▼ -81.4%
2014 0.84x €3.58 Million €3.00 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow